Vol 13 No 3S (2012) | Farmeconomia. Health economics and therapeutic pathways

Skip to main content Skip to main navigation menu Skip to site footer

Published: 2012-12-14

Editorial

Generic and biosimilar medicines: quid?

Steven Simoens

3-4
- HTML
- PDF

Review (Economic Analysis)

Essential to increase the use of generics in Europe to maintain comprehensive health care?

Brian Godman, Marion Bennie, Christoph Baumgärtel, Ljiljana Sović-Brkičić, Thomas Burkhardt, Jurij Fürst, Kristina Garuoliene, Miguel Gomes, Vanda Markovic-Pekovic, Andrew Martin, Catherine Sermet, Peter Skiold, Menno van Woerkom, Luka Voncina, Lars L. Gustafsson

5-20
- HTML
- PDF

Original research

From generic to biosimilar drugs: why take an innovative pace?

Fereshteh Barei, Claude Le Pen, Steven Simoens

21-27
- HTML
- PDF
How large are the differences between originator and generic prices? Analysis of five molecules in 16 European countries

Sabine Vogler

29-41
- HTML
- PDF